Drug intelligence / Profile preview

Estetrol + progesterone

Development stage
Preclinical
Lead developer
Mithra Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

Estetrol + progesterone is a combination of two hormones used primarily for hormonal contraception. Estetrol is a native estrogen produced by the human fetal liver during pregnancy, but it can also be synthesized from plant sources. It acts as a selective estrogen receptor modulator with moderate affinity for both estrogen receptor alpha (ERα) and beta (ERβ), showing tissue-selective agonist activity on the vagina, uterus, and endometrium, while exhibiting antagonistic effects on breast tissue[5][6][7]. Progesterone is a natural progestogen that binds to and activates the progesterone receptor to regulate reproductive function. The combination suppresses ovulation as its primary mechanism of action, thereby preventing pregnancy[2][7]. This dual-hormone approach mimics endogenous hormonal cycles more closely than traditional synthetic estrogens and may offer improved safety profiles regarding thrombotic risk compared to ethinylestradiol-containing contraceptives[2][7]. While estetrol in combination with drospirenone has been approved for contraception (e.g., under the brand name Nextstellis), combinations with natural progesterone are still under investigation or development.

02

Targets

PR (Progesterone receptor)ESR2 (ERβ)ESR1 (ERα)

Beyond the preview

Go deeper on Estetrol + progesterone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Estetrol + progesterone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call